Response to 'Correspondence on 'Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study'' by Zheng et al.
Ann Rheum Dis
; 81(11): e225, 2022 11.
Article
em En
| MEDLINE
| ID: mdl-33177102
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Artrite Reumatoide
/
Produtos Biológicos
/
Antirreumáticos
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article